One paper, ContextMRI, is accepted to Medical Image Analysis.
Hyungjin is selected as a World Top 2% Scientist 2026, ranking 3rd in Korea in both AI and ICT by citations to single- and first-authored papers.
Four papers, AVIS, StitchVM, EPS, and MVVBench (E&D track), are accepted to NeurIPS 2026.
Hyungjin is serving as an Area Chair for ICLR 2027.
Two papers, InverseCrafter and ReDesign, are accepted to ECCV 2026.
Hyungjin is recognized as a Gold Reviewer for ICML 2026.
One paper, Contrastive CFG, is accepted to ICML 2026.
Two papers, ReDirector and Video Parallel Scaling, are accepted to CVPR 2026.
One paper, Stochastic Optimal Control for Continuous-Time fMRI Representation Learning, is accepted to ICLR 2026.
Hyungjin is selected as a World Top 2% Scientist 2025.
One paper, InvFusion, is accepted to NeurIPS 2025.